Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

Podcast TCTMD Talking Points

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

July 06, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

Cath Labs Trying to Get Back on Track With Documentation, Quality Measures

News Conference News SCAI 2022

Cath Labs Trying to Get Back on Track With Quality Measures, Documentation

L.A. McKeown

May 27, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News HRS 2022

Fewer Lead-Related Complications With Subcutaneous ICD: ATLAS S-ICD

Todd Neale

April 30, 2022

News Conference News ACC 2022

Better Angina Relief With Complete PCI in STEMI and MVD

L.A. McKeown

April 02, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Video

Coronary IVL: News & Take Aways from TCT 2022

November 1, 2022

Video

Does Calcium Morphology Matter? Coronary IVL Real World Experience from Europe

November 1, 2022

Partner Content

Lifetime Patient Management and the Importance of TAVR Hemodynamics

October 27, 2022

Video

Lifetime Patient Management and the Importance of TAVR Hemodynamics

October 27, 2022

Video

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

October 6, 2022

Video

» Topical Discussion

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

September 30, 2022

Video

» Topical Discussion

Achieving Excellent Hemodynamics with a Self-Expanding Intra-Annular Valve

August 24, 2022

Video

Aortic Regurgitation in 2022- Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

July 13, 2022

Advertisement

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk

Minorities, Poorer Patients Missing Out on Structural Heart Care

Cath Labs Trying to Get Back on Track With Quality Measures, Documentation

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Fewer Lead-Related Complications With Subcutaneous ICD: ATLAS S-ICD

Better Angina Relief With Complete PCI in STEMI and MVD

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Coronary IVL: News & Take Aways from TCT 2022

Does Calcium Morphology Matter? Coronary IVL Real World Experience from Europe

Lifetime Patient Management and the Importance of TAVR Hemodynamics

Lifetime Patient Management and the Importance of TAVR Hemodynamics

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve

Achieving Excellent Hemodynamics with a Self-Expanding Intra-Annular Valve

Aortic Regurgitation in 2022- Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content